Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY-NC-NDCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Neurokinin-3 receptor antagonists for vasomotor symptoms in menopause and breast cancer survivorship.

  1. 1Faculty of Medicine (Feng), McGill University, Montréal, Que.; Departments of Family Medicine (Wilkinson) and of Obstetrics and Gynecology (Delpero), University of Ottawa; Division of Medical Oncology (Srikanthan), The Ottawa Hospital; Department of Medicine (Srikanthan), University of Ottawa; Ottawa Hospital Research Institute (Srikanthan), Ottawa, Ont.
  2. 2Faculty of Medicine (Feng), McGill University, Montréal, Que.; Departments of Family Medicine (Wilkinson) and of Obstetrics and Gynecology (Delpero), University of Ottawa; Division of Medical Oncology (Srikanthan), The Ottawa Hospital; Department of Medicine (Srikanthan), University of Ottawa; Ottawa Hospital Research Institute (Srikanthan), Ottawa, Ont. [email protected].

Related

  1. Association of co-administration of neurokinin-1 receptor antagonists and dexamethasone with new-onset diabetes in patients receiving chemotherapy: a retrospective cross-sectional study using health claims database in Japan.
    Yuki Ozawa, Shinya Suzuki, Takuma Koinuma +5
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  2. Non-Hormonal Psychopharmacotherapy of Vasomotor Symptoms Related to Menopause
    Ahmed Naguy, Nour Jassim Alsalem, Anubhuti Singh
    Psychopharmacology BulletinPeer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
  3. Estradiol for persistent vasomotor symptoms after surgical menopause in a transgender man
    Macie Narbonne, Michelle Jacobson, Tehmina Ahmad
    CMAJ : Canadian Medical Association JournalPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismPMC
  4. Non-Hormonal Treatments for Vasomotor Symptoms of Menopause: An Up-to-Date Review.
    Ala'a S Farhan, Hetaf S Farhan, Mohammed T Dinfash
    CureusPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
  5. Women’s Treatment Preferences for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Insights from the WARMER Study
    Sebastian Heidenreich, Tommaso Simoncini, Katelyn Cutts +6
    The PatientPeer-reviewedCC BY-NC 4.0Full textEndocrinology & metabolismPMC
BibTeX
@article{feng2026neurokinin3,
  title = {{Neurokinin-3 receptor antagonists for vasomotor symptoms in menopause and breast cancer survivorship.}},
  author = {Nadia Linxi Feng and Anna N Wilkinson and Emily Delpero and Amirrtha Srikanthan},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year = {2026},
  month = oct,
  doi = {10.1503/cmaj.260911},
  url = {https://europepmc.org/article/MED/42896883},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Neurokinin-3 receptor antagonists for vasomotor symptoms in menopause and breast cancer survivorship.
AU  - Nadia Linxi Feng
AU  - Anna N Wilkinson
AU  - Emily Delpero
AU  - Amirrtha Srikanthan
PY  - 2026
DA  - 2026/10/18
JO  - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
DO  - 10.1503/cmaj.260911
UR  - https://europepmc.org/article/MED/42896883
SN  - 0820-3946
SN  - 1488-2329
ER  -